子宫内膜癌患者腹水细胞学阳性的相关因素及其对预后的影响  

Factors Relevant to Positive Peritoneal Cytology in Endometrial Cancer Patients and Its Influence on Prognosis

作　　者：刘红 张国楠 Liu Hong;Zhang Guonan(Gynecologic Oncology Center,Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,Sichuan,China)

机构地区：[1]四川省肿瘤医院•研究所,四川省癌症防治中心,电子科技大学医学院妇科肿瘤中心,成都6610041

出　　处：《肿瘤预防与治疗》2022年第6期565-571,共7页Journal of Cancer Control And Treatment

基　　金：四川省医学重点学科和重点专科建设项目基金(编号:川卫办发[2007]407号)。

摘　　要：目前对于腹水细胞学阳性是否影响子宫内膜癌患者的预后,国内外仍存在争论。尽管根据现行FIGO 2009分期,细胞学检查不会影响分期,但仍应考虑其临床意义对这些患者进行准确的危险分层。临床上应重视对腹水细胞学的检查,以指导临床治疗决策。本文将从子宫内膜癌腹水肿瘤细胞的来源,影响腹水细胞学检查阳性率的相关因素及其对预后和辅助治疗策略选择的影响进行综述。At present,whether positive peritoneal cytology affects the prognosis of endometrial cancer patients is still controversial at home and abroad.Although peritoneal cytology will not affect staging according to current FIGO 2009 staging system,its clinical significance should still be taken into consideration,and the risk should be accurately stratified for these patients.We should pay attention to the detection of peritoneal cytology in order to guide clinical decision-making.This article will review sources of peritoneal tumor cells of endometrial cancer,factors affecting the positive rate of peritoneal cytology,and its influence on prognosis and options of adjuvant treatments.

关 键 词：子宫内膜癌 腹水细胞学 预后 

分 类 号：R737.33[医药卫生—肿瘤] R730.231[医药卫生—临床医学] R730.7